Organization · Venture Capital
Atlas Venture
Atlas Venture is a biotechnology venture capital firm based in Cambridge, Massachusetts, focusing on early-stage biotech companies. They emphasize a collaborative, science-first approach to drug development.
Overview
What Atlas Venture does
What Atlas Venture is
Atlas Venture is a biotechnology venture capital firm based in Cambridge, Massachusetts, focusing on early-stage biotech companies. They emphasize a collaborative, science-first approach to drug development.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1993
- Approximate age
- About 33 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find Atlas Venture elsewhere
Open the official website or a supported primary organization account.
Capability profile
Atlas Venture as a funder
Investment thesis
Seed-led biotech venture creation. Translates high-impact science into medicines by working alongside scientists and entrepreneurs. Building scalable biotech businesses.
Focus narrative
Seed-led venture creation translating high-impact science into medicines. Works alongside exceptional scientists and entrepreneurs.
Value beyond capital
Atlas provides hands-on venture creation alongside scientists, translating academic research into scalable biotech businesses and medicines for patients.
Terms and economics
- Typical check
- $2,000,000–$15,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Investments in the last 12 months
- 8
- Last recorded investment
- December 1, 2025
Portfolio context
Focused biotech portfolio with seed-led venture creation approach.
Capability profile
Atlas Venture as a publisher
Editorial focus
Atlas Venture is a biotechnology venture capital firm that has been creating and building breakthrough biotech companies for over 30 years. Based in Cambridge, Massachusetts, the firm emphasizes a collaborative, science-first, and patient-centric approach to drug development, specifically targeting early-stage companies in the biotech sector.
Audience value
Atlas Venture provides strategic investment and support to early-stage biotech companies, leveraging their expertise to foster innovation in drug development.
Format and cadence
- Content formats
- newsletter and blog
- Primary platform
- Website
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors · Founders
- Sectors
- Biotech & Life Sciences
- Regions
- United States
Flagship work and coverage
Flagship properties
Atlas Venture publishes the 'Atlas Venture 2024 Newsletter' and 'Atlas Venture 2025 Newsletter', along with a blog featuring articles on decision-making frameworks, biotech venture creation, and stock option repricing.
Common questions
What to know about Atlas Venture
Upseed classifies Atlas Venture under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.